InvestInfoAI
Rubric Capital Management LP

Q1 2026 · 13F-HR

Rubric Capital Management LPholdings as filed

Filed 2026-05-15 · accession 0001104659-26-062466

$9.44B
Reported value
83
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · Rubric Capital Management LP · Q1 2026

AI · grounded in 13F

Rubric Capital Management LP established a new position in IWM valued at $1.28B. The fund also opened a new position in ZNGA for $80.47M and increased its stake in GIL by 444.38%. On the sell side, the fund closed its position in FLR, exiting the holding for $164.22M.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
464287655IWMISHARES TR$1.28B13.5%5,150,000PUTSOLE
87422Q109TLNTALEN ENERGY CORP$1.15B12.2%3,602,171CommonSOLE
G3730V105FTAIFTAI AVIATION LTD$631.2M6.69%2,576,186CommonSOLE
G9456A100GLNGGOLAR LNG LTD$496.7M5.26%9,178,978CommonSOLE
881624209TEVATEVA PHARMACEUTICAL INDS LTD$459.3M4.87%15,250,000CommonSOLE
92556V106VTRSVIATRIS INC$452.6M4.79%33,500,000CommonSOLE
89346D107TACTRANSALTA CORP$232.9M2.47%17,781,325CommonSOLE
088929104BGCBGC GROUP INC$227.9M2.41%23,300,000CommonSOLE
92840M102VSTVISTRA CORP$225.5M2.39%1,500,000CommonSOLE
21037T109CEGCONSTELLATION ENERGY CORP$199.7M2.12%715,000CommonSOLE
03969K108ARQTARCUTIS BIOTHERAPEUTICS INC$194.9M2.06%8,271,577CommonSOLE
589400100MCYMERCURY GENL CORP NEW$189.9M2.01%2,154,504CommonSOLE
G52694109KNSAKINIKSA PHARMACEUTICALS INTL$180.6M1.91%3,750,000CommonSOLE
98985Y108ZYMEZYMEWORKS INC$175.3M1.86%7,000,000CommonSOLE
00971T101AKAMAKAMAI TECHNOLOGIES INC$149.3M1.58%1,300,000CommonSOLE
G61188101LBTYALIBERTY GLOBAL LTD$142.1M1.51%11,752,855CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$138.5M1.47%5,000,000CommonSOLE
03168L105AMRXAMNEAL PHARMACEUTICALS INC$137.2M1.45%11,037,589CommonSOLE
G9001E128LILAKLIBERTY LATIN AMERICA LTD$135.8M1.44%15,395,430CommonSOLE
24665A103DKDELEK US HLDGS INC NEW$121.1M1.28%2,687,449CommonSOLE
G2143T103CMPRCIMPRESS PLC$118.9M1.26%1,629,419CommonSOLE
27923Q109ECVTECOVYST INC$117.5M1.24%9,136,067CommonSOLE
G61188127LBTYKLIBERTY GLOBAL LTD$108.6M1.15%9,259,361CommonSOLE
00676P107ADEAADEIA INC$102.9M1.09%4,284,205CommonSOLE
28035Q102EPCEDGEWELL PERSONAL CARE CO$85.4M0.90%4,000,000CommonSOLE
98980L101ZNGAZOOM COMMUNICATIONS INC$80.5M0.85%1,001,006CommonSOLE
879433829TDSTELEPHONE & DATA SYS INC$77.9M0.83%1,850,000CommonSOLE
375916103GILGILDAN ACTIVEWEAR INC$77.7M0.82%1,395,790CommonSOLE
457985208IARTINTEGRA LIFESCIENCES HLDGS C$73.0M0.77%7,753,934CommonSOLE
80810D103SDGRSCHRODINGER INC$68.2M0.72%6,000,000CommonSOLE
82835W108SPRYARS PHARMACEUTICALS INC$64.2M0.68%8,000,000CommonSOLE
36162J106GEOGEO GROUP INC$62.9M0.67%3,743,180CommonSOLE
M85548101SSYSSTRATASYS LTD$62.5M0.66%8,000,000CommonSOLE
034164103ANDEANDERSONS INC$61.4M0.65%855,819CommonSOLE
G59665102MGTXMEIRAGTX HLDGS PLC$60.6M0.64%7,000,000CommonSOLE
194014502ENOVENOVIS CORPORATION$55.8M0.59%2,453,265CommonSOLE
68375N103OPKOPKO HEALTH INC$54.5M0.58%47,791,243CommonSOLE
219798105QDELQUIDELORTHO CORP$54.3M0.58%3,306,281CommonSOLE
741623102PRMBPRIMO BRANDS CORPORATION$52.4M0.56%2,782,404CommonSOLE
651229106NWLNEWELL BRANDS INC$52.3M0.55%15,257,431CommonSOLE
G0250X149AMCRAMCOR PLC$50.5M0.53%1,269,396CommonSOLE
G7500M104RNWRENEW ENERGY GLOBAL PLC$50.4M0.53%11,000,000CommonSOLE
G72800108PRTAPROTHENA CORP PLC$48.6M0.51%5,000,000CommonSOLE
74366E102PTGXPROTAGONIST THERAPEUTICS INC$45.1M0.48%427,998CommonSOLE
89532M101TRVITREVI THERAPEUTICS INC$44.3M0.47%3,712,373CommonSOLE
68752M108OFIXORTHOFIX MED INC$42.7M0.45%3,721,715CommonSOLE
19459J104COLLCOLLEGIUM PHARMACEUTICAL INC$42.3M0.45%1,279,611CommonSOLE
21871N101CXWCORECIVIC INC$38.9M0.41%2,059,216CommonSOLE
67080M103NRIXNURIX THERAPEUTICS INC$38.3M0.41%2,473,885CommonSOLE
26210V102DRVNDRIVEN BRANDS HLDGS INC$37.8M0.40%3,000,000CommonSOLE
128246105CVGWCALAVO GROWERS INC$36.5M0.39%1,416,662CommonSOLE
146229109CRICARTERS INC$36.4M0.39%1,018,853CommonSOLE
20337X109VISNVISTANCE NETWORKS INC$36.4M0.39%2,000,000CommonSOLE
808541106MATVMATIV HOLDINGS INC$34.6M0.37%3,982,442CommonSOLE
G9001E102LILALIBERTY LATIN AMERICA LTD$32.4M0.34%3,750,000CommonSOLE
879512309TSATTELESAT CORP$30.5M0.32%843,781CommonSOLE
03879J100ABUSARBUTUS BIOPHARMA CORP$29.8M0.32%6,626,389CommonSOLE
743713109PRLBPROTO LABS INC$27.7M0.29%486,400CommonSOLE
20464U100COMPCOMPASS INC$27.4M0.29%3,746,848CommonSOLE
09061G101BMRNBIOMARIN PHARMACEUTICAL INC$24.9M0.26%440,560CommonSOLE
427746102HRTXHERON THERAPEUTICS INC$24.0M0.25%30,046,828CommonSOLE
60510V108AVOMISSION PRODUCE INC$23.8M0.25%1,726,447CommonSOLE
92333F101VGVENTURE GLOBAL INC$23.6M0.25%1,500,000CommonSOLE
98423J101XPERXPERI INC$23.2M0.25%4,143,744CommonSOLE
87615L107THTARGET HOSPITALITY CORP$20.3M0.22%2,189,456CommonSOLE
45579U109INDVINDIVIOR PHARMACEUTICALS INC$20.2M0.21%662,515CommonSOLE
00404A109ACHCACADIA HEALTHCARE COMPANY IN$19.9M0.21%850,000CommonSOLE
000899104ADMAADMA BIOLOGICS INC$16.3M0.17%1,809,408CommonSOLE
67011P100DNOWDNOW INC$15.1M0.16%1,267,527CommonSOLE
812215200SEGSEAPORT ENTMT GROUP INC$12.2M0.13%568,530CommonSOLE
G1890L107CPRICAPRI HOLDINGS LIMITED$11.9M0.13%675,000CommonSOLE
039697107ARDXARDELYX INC$11.1M0.12%1,860,896CommonSOLE
29082K105EMBCEMBECTA CORP$9.2M0.10%1,037,416CommonSOLE
56400P706MNKDMANNKIND CORP$8.9M0.09%3,620,413CommonSOLE
40054J109AEROGRUPO AEROMEXICO SAB DE CV$6.5M0.07%467,129CommonSOLE
G4388N106HELEHELEN OF TROY LTD$5.3M0.06%366,226CommonSOLE
589492107MREOMEREO BIOPHARMA GROUP PLC$5.1M0.05%15,307,347CommonSOLE
29842P105EPRXEUPRAXIA PHARMACEUTICALS INC$5.0M0.05%691,170CommonSOLE
70932M107PFSIPENNYMAC FINL SVCS INC NEW$4.8M0.05%54,727CommonSOLE
27966L306EDSAEDESA BIOTECH INC$3.6M0.04%687,500CommonSOLE
88338N206TXMDTHERAPEUTICSMD INC$2.4M0.03%1,192,191CommonSOLE
68375NAG8OPK 3.75 01/15/29OPKO HEALTH INC$1.5M0.02%1,250,000CommonSOLE
72815G108MYPSPLAYSTUDIOS INC$1.3M0.01%2,697,384CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.